FACTANKER

iTeos Therapeutics, Inc.: cashflow_investing

Value{"amount": -837000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2022-01-01 – 2022-06-30
Statuscurrent
EntityiTeos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-22-016471
Retrieved: 2026-08-19T18:13:01.793164+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/4e86c436-7520-4ea7-ab2f-d4e44603446f

History